Drug
Abt 450 Ritonavir
Abt 450 Ritonavir: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABT-450/ritonavir (r) NCT02068222 | Phase 2 | Chronic Hepatitis C |
Latest
No recent events.
Follow Abt 450 Ritonavir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.